CASC17 and Parkinson disease: They are used as a standard method to test for variant association in GWAS, and helped identify several variants associated with PD including SNCA, MAPT, GBA and HLA loci as well as others associated with cognitive decline in PD including APOEε4, RYR2 and CASC17 loci.